key articles
Effect of nightly versus on demand vardenafil on recovery of erectile function following bilateral nerve-sparing radical prostatectomy
Wednesday, 13 August 2008 - To date, no data have been available from large, well-designed trials comparing on demand and nightly dosing of phosphodiesterase type 5 (PDE5) inhibitors on recovery of erectile function in...
Authors: Montorsi et al.
Testosterone and erectile dysfunction
Monday, 11 August 2008 - In a review, Yassin and Saad (2008) discussed the relationship between testosterone and rectile dysfunction (ED). ED is defined as the inability to achieve or maintain erections sufficient for...
Authors: Yassin & Saad
Dark side of testosterone deficiency: Metabolic syndrome and erectile dysfunction
Saturday, 9 August 2008 - Metabolic Syndrome (MetS) is the most important public health threat of the 21st Century. This syndrome is characterized by a cluster of cardiovascular risk factors including increased central abdominal...
Authors: Traish et al.
Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy
Tuesday, 5 August 2008 - Boorjian et al. (2008) investigated the impact of body mass index (BMI) on pathologic and functional outcomes after robot-assisted laparoscopic prostatectomy (RALP).
The authors evaluated 400 consecutive...
Authors: Boorjian et al.
Sildenafil citrate (Viagra) improves erectile function and lower urinary tract symptoms
Friday, 1 August 2008 - McVary et al. (2008) evaluated the body mass index (BMI) and lower urinary tract symptom (LUTS) severity on treatment response to sildenafil in men with erectile dysfunction (ED) and moderate to severe...
Authors: McVary et al.
Testosterone improves erectile function in hypogonadal patients with venous leakage
Wednesday, 30 July 2008 - Kurbatov et al. (2008) assessed the therapeutic benefits of long-acting testosterone therapy in hypogonadal patients with erectile dysfunction (ED).
The authors recruited 29 patients with ED ranging in...
Authors: Kurbatov et al.
Oral phosphodiesterase-5 inhibitors and sperm functions
wednesday, 30 July 2008 - In a review, Mostafa (2008) elucidated the possible effects of phosphodiesterase-5 (PDE5) inhibitors on sperm functions. PDEs hydrolyze cyclic nucleotides, and together with adenylyl and guanylyl...
Author: Mostafa
Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome
Tuesday, 29 July 2008 - Pathogenesis of erectile dysfunction (ED) is related to endothelial dysfunction and therefore associated with cardiovascular risk factors. Patients with a combination of risk factors, as in metabolic...
Authors: Baumhakel et al.
Clinical applications of centrally acting agents in male sexual dysfunction
Friday, 25 July 2008 - Currently available agents for erectile dysfunction (ED) share the same mechanism of action and pharmacologic properties. Therefore, they share the same limitations, including a principal focus on erection...
Author: Hellstrom
Epidemiology and pathophysiology of male sexual dysfunction
Thursday, 24 July 2008 - Male sexual dysfunction (MSD) is a common disorder associated with a wide range of physical and psychological conditions. Erectile dysfunction, the most commonly studied aspect of MSD, is common and...
Author: Kaminetsky
